3619-73-6

Basic information

• Product Name: 1-ETHYLHOMOPIPERAZINE
• Synonyms: 1-ETHYLHOMOPIPERAZINE;N-ETHYLHEXAMETHYLENEIMINE;1-ETHYLHOMOPIPERAZINE, 98+%;1-ethyl-1,4-diazepane(SALTDATA: 2HCl);N-ethy1 Homo-Piperazines;1-Ethylhexahydro-1H-1,4-diazepine;N-Ethylhomopiperazine
• CAS NO: 3619-73-6
• Molecular Formula: C₇H₁₆N₂
• Molecular Weight: 127.23
• EINECS: -0
• Mol File: 3619-73-6.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 72°C 12mm
• Flash Point: 72°C/12mm
• Appearance: /
• Density: 0,904 g/cm3
• Vapor Pressure: 1.17mmHg at 25°C
• Refractive Index: 1.4780
• Storage Temp.: 2-8°C(protect from light)
• PKA: 10.61±0.20(Predicted)
• Sensitive: Air Sensitive
• BRN: 605511
• CAS DataBase Reference: 1-ETHYLHOMOPIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-ETHYLHOMOPIPERAZINE(3619-73-6)
• EPA Substance Registry System: 1-ETHYLHOMOPIPERAZINE(3619-73-6)

Safety Data

• Statements: 34
• Safety Statements: 26-36/37/39-45
• RIDADR: 2735
• HazardClass: 8
• PackingGroup: II
• Hazardous Substances Data: 3619-73-6(Hazardous Substances Data)

Usage

Chemical Properties

Colorless liquid

InChI:InChI=1/C7H16N2/c1-2-9-6-3-4-8-5-7-9/h8H,2-7H2,1H3

Upstream product

• 1609534-99-7 1-(benzyl carboxy)-4-ethyl-homopiperazine 
• 117009-97-9 benzyl 1,4-diazepane-1-carboxylate 
• 61903-11-5 N-acetylhomopiperizine 
• 505-66-8 1,4-Diazacycloheptane 
• 75-03-6 ethyl iodide 

Downstream Products

• 1035270-54-2 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-5-(4-ethyl-1,4-diazepan-1-yl)pyrazine-2-carboxamide 
• 1177252-48-0 1-[(1-benzyl-1H-tetrazol-5-yl)(4-fluorophenyl)methyl]-4-ethyl-1,4-diazepane 
• 1609535-02-5 1,1-diethyl-4-(phenyl-4-benzyloxy)-homopiperazinium tosylate 
• 1609534-96-4 1,1-diethyl-4-(phenyl-4-hydroxy)-homopiperazinium tosylate 
• 1609535-00-3 1-(phenyl-4-benzyloxy)-4-ethyl-homopiperazine 
• 1265396-99-3 methyl 2-(2-(4-ethyl-1,4-diazepan-1-yl)-4-methyl-6-p-tolylpyrimidin-5-yl)pentanoate 
• 530098-49-8 4-ethylhomopiperazin-1-ylacetate 

Relevant articles and documents

METHOD FOR USE OF HOMOPIPERAZINIUM COMPOUNDS IN THE TREATMENT OF CANCER

The present disclosure relates to a method for treating cancer comprising administering to a patient in need thereof an effective amount of a compound having the formula: (Formula (I)) wherein R1, R2, Ya, Xa, and J- are as defined herein.

NOVEL COMPOUNDS

There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.

Benzoheterocyclic derivatives

PCT No. PCT/JP95/01124 Sec. 371 Date Nov. 13, 1996 Sec. 102(e) Date Nov. 13, 1996 PCT Filed Jun. 7, 1995 PCT Pub. No. WO95/34540 PCT Pub. Date Dec. 21, 1995A benzoheterocyclic derivative of the following formula [1]: and pharmaceutically acceptable salts